CDK6 and central nervous system cancer: It is worth noting that there may be other biomarkers for response such as amplification of D-type cyclins, CDK4 or CDK6 amplifications- all of which are present in DIPGs and other pediatric high-grade gliomas [3–5,16,18,20].